T Lymphocytes Play a Critical Role in the Development of Cyclosporin A-Induced Osteopenia

Endocrinology

Volumn 137, Issue 6, 1996, Pages 2278-2285

  Buchinsky, Farrel J ^a   Ma, Yanfei ^b   Mann, Gary N ^a   Rucinski, Boguslaw ^a   Bryer, Haldon P ^a   Romero, David F ^a   Jee, Webster S S ^b   Epstein, Solomon ^a  

^a ALBERT EINSTEIN MEDICAL CENTER   (United States)

^b UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE ATROPHY; BONE MASS; BONE REMODELING; CALCIUM METABOLISM; CONTROLLED STUDY; DRUG INDUCED DISEASE; MORPHOMETRICS; NONHUMAN; OSTEOPENIA; OSTEOPOROSIS; PRIORITY JOURNAL; RAT; T LYMPHOCYTE ACTIVATION; TRABECULAR BONE;

ANIMALS; BLOOD GLUCOSE; BONE AND BONES; BONE DISEASES, METABOLIC; CALCITRIOL; CALCIUM; CREATININE; CYCLOSPORINE; IMMUNOSUPPRESSIVE AGENTS; MALE; OSTEOCALCIN; PARATHYROID HORMONE; RATS; RATS, NUDE; RATS, SPRAGUE-DAWLEY; T-LYMPHOCYTES; UREA;

EID: 0029950919     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.137.6.8641176     Document Type: Article

References (58)

1. Kahan BD 1989 Cyclosporine. N Engl J Med 321:1725-1738
2. Miller LW, Pennington DG, McBride LR 1990 Long-term effects of cyclosporine in cardiac transplantation. Transplant Proc 22:15-20
3. Ellis CN, Gorsulowsky DC, Hamilton TA, Billings JK, Brown MD, Headington JT, Cooper KD, Baadsgaard O, Duell EA, Annesley TM, Turcotte JG, Voorhees JJ 1986 Cyclosporin improves psoriasis in a double-blind study. JAMA 256:3110-3116
4. Sowden JM, Berth-Jones J, Ross JS, Motley RJ, Marks R, Finlay AY, Salek MS, Graham-Brown RAC, Allen BR, Camp RDR 1991 Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis. Lancet 338:137-140
5. Tugwell P, Bombardier C, Gent M, Bennett KJ, Bensen WG, Carette S, Chalmers A, Esdaile JM, Klinkhoff AV, Kraag GR, Ludwin D, Roberts RS 1990 Low-dose cyclosporin vs. placebo in patients with rheumatoid arthritis. Lancet 335:1051-1055
6. Nussenblatt RB, Palestine AG, Chan CC 1983 Cyclosporin A therapy in the treatment of intraocular inflammatory disease resistant to systemic corticosteroids and cytotoxic agents. Am J Opthalmol 96:275-282
7. Katz IA, Epstein S 1992 Posttransplantation bone disease. J Bone Miner Res 7:123-126
8. McDonald JA, Dunstan CR, Dilworth P, Sherbon K, Ross Sheil AG, Evans RA, McCaughan GW 1991 Bone loss after liver transplantation. Hepatology 14:613-619
9. Bressot C, Meunier PJ, Chapuy MC, Lejeune E, Edouard C, Darby AJ 1979 Histomorphometric profile, pathophysiology and reversibility of corticosteroid-induced osteoporosis. Metab Bone Dis Rel Res 1:303-311
10. Lukert BP, Raisz LG 1990 Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Intern Med 112:352-364
11. Bryer HP, Isserow JA, Armstrong EC, Mann GN, Rucinski B, Buchinsky FJ, Romero DF, Epstein S 1995 Azathioprine alone is bone sparing and does not alter cyclosporin A induced osteopenia in the rat. J Bone Miner Res 10:132-138
12. Aubia J, Masramon J, Serrano S, Lloveras J, Marinoso LL 1988 Bone histology in renal transplant patients receiving cyclosporin. Lancet 1:1048-1049
13. Loertscher R, Thiel G, Harder F, Brunner FP 1982 Persistent elevation of alkaline phosphatase in cyclosporine-treated renal transplant recipients. Transplantation 36:115-116
14. Shane E, Rivas MDC, Silverberg SJ, Kim TS, Staron RB, Bilezikian JP 1993 Osteoporosis after cardiac transplantation. Am J Med 94: 257-264
15. Rich GM, Mudge GH, Laffel GL, LeBoff MS 1992 Cyclosporine A and prednisone-associated osteoporosis in heart transplant recipients. J Heart Lung Transplant 11:950-958
16. Hawkins FG, Leon M, Lopez MB, Valero MA, Larrodera L, Garcia-Garcia I, Loinaz C, Moreno Gonzalez E 1994 Bone loss and turnover in patients with liver transplantation. Hepato-Gastroenterol 41:158-161
17. Sambrook PN, Kelly PJ, Fontana D, Nguyen T, Keogh A, Macdonald P, Spratt P, Freund J, Eisman JA 1994 Mechanisms of rapid bone loss following cardiac transplantation. Osteoporosis Int 4:273-276
18. Movsowitz C, Epstein S, Ismail F, Fallon M, Thomas S 1989 Cyclosporin A in the oophorectomized rat: unexpected severe bone resorption. J Bone Miner Res 4:393-398
19. Movsowitz C, Epstein S, Fallon M, Ismail F, Thomas S 1988 Cyclosporin A in vivo produces severe osteopenia in the rat: effect of dose and duration of administration. Endocrinology 123:2571-2577
20. Schlosberg M, Movsowitz C, Epstein S, Fallon MD, Thomas S 1989 The effect of cyclosporin A administration and its withdrawal on bone mineral metabolism in the rat. Endocrinology 124:2179-2184
21. Orcel P, Denne MA, De Vernejoul MC 1991 Cyclosporin-A in vitro decreases bone resorption, osteoclast formation, and the fusion of cells of the monocyte-macrophage lineage. Endocrinology 128:1638-1646
22. Klaushofer K, Hoffmann O, Stewart PJ, Cxerwenka E, Koller K, Peterlik M, Stern PH 1987 Cyclosporin A inhibits bone resorption in cultured neonatal mouse calvaria. J Pharmacol Exp Ther 243:584-590
23. Romero DF, Buchinsky FJ, Rucinski B, Cvetkovic M, Bryer HP, Liang XG, Ma YF, Jee WSS, Epstein S 1995 Rapamycin: a bone sparing immunosuppressant? J Bone Miner Res 10:760-768
24. Stewart PJ, Stern PH 1989 Cyclosporines: correlation of immunosuppressive activity and inhibition of bone resorption. Calcif Tissue Int 45:222-226
25. Rucinski B, Liu CC, Epstein S 1994 Utilization of cyclosporine H to elucidate the possible mechanisms of cyclosporine A-induced osteopenia in the rat. Metabolism 43:1114-1118
26. Festing MFW, May D, Connors TA, Lovell D, Sparrow S 1978 An athymic nude mutation in the rat. Nature 274:365-366
27. Committee on Immunologically Compromised Rodents Institute of Laboratory Animal Resources Commission on Life Sciences National Research Council 1989 Immunodeficient Rodents: A Guide to Their Immunobiology, Husbandry, and Use. National Academy Press, Washington DC
28. Buchinsky FJ, Ma YF, Mann GN, Rucinski B, Bryer HP, Paynton BV, Jee WSS, Hendy GN, Epstein S 1995 Bone mineral metabolism in T lymphocyte-deficient and -replete strains of rat. J Bone Miner Res 10:1556-1565
29. Price PA, Lothringer JW, Nishimoto SK 1980 Absence of the vitamin K-dependent bone protein in fetal rat mineral. Evidence for another gamma-carboxyglutamic acid-containing component in bone. J Biol Chem 255:2938-2942
30. Rucinski B, Mann GN, Epstein S 1995 A new rapid and reproducible homologous immuno radiometric assay for amino terminal parathyroid hormone in the rat. Calcif Tissue Int 56:83-87
31. Jee WSS, Inoue J, Jee KW, Haba T 1983 Histomorphometric assay of the growing long bone In: Takahashi H (ed) Handbook of Bone Morphology. Nishimura, Niigata City, pp 101-122
32. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR 1987 Bone histomorphometry: standardization of nomenclature, s and units. Report of the ASBMR Histomorphometry Committee. J Bone Miner Res 2:595-610
33. Katz I, Li M, Joffe I, Stein B, Jacobs T, Liang X, Ke H, Jee W, Epstein S 1994 The influence of age on cyclosporin A-induced alterations in bone mineral metabolism in the rat in vivo. J Bone Miner Res 9:59-67
34. 3. Mineral Electrolyte Metab 10:375-378
35. Imai T, Tsunenari T, Fukase M, Fujita T 1990 Quantitative bone histomorphometry and circulating T lymphocyte subsets in postmenopausal osteoporosis. J Bone Miner Res 5:393-399
36. Rosen CJ, Usiskin K, Owens M, Barlascini CO, Belsky M, Adler RA 1990 T lymphocyte surface antigen markers in osteoporosis. J Bone Miner Res 5:851-855
37. Horowitz M, Vignery A, Gershon RK, Baron R 1984 Thymus-derived lymphocytes and their interactions with macrophages are required for the production of osteoclast-activating factor in the mouse. Proc Natl Acad Sci USA 81:2181-2185
38. 3 in the rat and mouse. Endocrinology 128:1369-1373
39. Helmchen U, Schmidt WE, Siegel E, Creutzfeldt W 1984 Morphological and functional changes in pancreatic B cells in cyclosporin A-treated rats. Diabetologia 27:416-418
40. Hahn HJ, Laube F, Klöting I, Kauert C, Lucke S, Besch W 1984 Effect of cyclosporin A on rat pancreatic β-cells in vivo and in vitro. Eur J Clin Invest 14:132A
41. Jacobs TW, Epstein S 1992 Current status of serum-derived bone proteins In: Davidovitch Z (ed) The Biological Mechanisms of Tooth Movement and Craniofacial Adaptation. Ohio State University College of Dentistry, Columbus, pp 149-158
42. Delmas PD, Malaval L, Arlot MD, et al 1986 Serum bone gla-protein is not a sensitive marker of bone turnover in Paget's disease of bone. Calcif Tissue Int 38:329
43. Kerner SA, Scott RA, Pike JW 1989 Sequence elements in the human osteocalcin gene confer basal activation and inducible response to hormonal vitamin D3. Proc Natl Acad Sci USA 86:4455-4459
44. Lian J, Stewart C, Puchacz E 1989 Structure of the rat osteocalcin gene and regulation of vitamin D-dependent expression. Proc Natl Acad Sci USA 86:1143
45. N (nznu, New Zealand nude) rat: an update. ILAR News 34:3-12
46. Hougen HP, Klausen B 1987 The thymus reconstituted nude rat: Lymphocyte subpopulations and immunological characteristics. Thymus 10:207-217
47. Brooks CG, Webb PJ, Robins RA, et al 1980 Studies on the immunobiology of rnu/rnu "nude" rats with congenital aplasia of the thymus. Eur J Immunol 10:58-65
48. Schwinzer R, Hedrich HJ, Wonigeit k 1987 The alloreactive potential of T-like cells from athymic nude rats (rnu/rnu). Trans Proc 19:285-287
49. Friedman J, Weissman I 1991 Two cytoplasmic candidates for immunophilin action are revealed by affinity for a new cyclophilin: one in the presence and one in the absence of CsA. Cell 66:799-806
50. Liu J, Farmer JD, Lane WS, Friedman J, Weissman I, Schreiber SL 1991 Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 66:807-815
51. Fruman DA, Klee CB, Bierer BE, Burakoff SJ 1992 Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A. Proc Natl Acad Sci USA 89:3686-3690
52. Schreiber SL 1991 Chemistry and biology of the immunophilins and their immunosuppressive ligands. Science 251:283-287
53. Schreiber SL, Crabtree GR 1992 The mechanism of action of cyclosporin A and FK506. Immunol Today 13:136-142
54. Herold KC, Lancki DW, Moldwin RL, Fitch FW 1986 Immunosuppressive effects of cyclosporin A on cloned T cells. J Immunol 136:1315-1321
55. Gowen M (ed) 1992 Cytokines and Bone Metabolism. CRC Press, Boca Raton
56. Li B, Sehajpal PK, Khanna A, Vlassara H, Cerami A, Stenzel KH, Suthanthiran M 1991 Differential regulation of transforming growth factor β and interleukin 2 genes in human T cells: demonstration by usage of novel competitor DNA constructs in the quantitative polymerase chain reaction. J Exp Med 174:1259-1262
57. Khanna A, Li B, Stenzel KH, Suthanthiran M 1994 Regulation of new DNA synthesis in mammalian cells by cyclosporine: demonstration of a transforming growth factor β-dependent mechanism of inhibition of cell growth. Transplantation 57:577-582
58. Mundy GR, Bonewald LF 1992 Tansforming growth factor beta. In: Gowen M (ed) Cytokines and Bone Metabolism. CRC Press, Boca Raton, pp 93-107